Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa

Metabolism: Clinical and Experimental

Volumn 46, Issue 12, 1997, Pages 1384-1389

  Baranowska, B ^a   Wasilewska Dziubinska E ^a   Radzikowska, M ^a   Plonowski A ^a   Roguski, K ^a  

^a MEDICAL CENTER FOR POSTGRADUATE EDUCATION   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GALANIN; LEPTIN; NEUROPEPTIDE Y;

ADULT; ANOREXIA NERVOSA; APPETITE; ARTICLE; BODY MASS; CONTROLLED STUDY; DIABETIC OBESITY; FEEDING BEHAVIOR; FEMALE; HUMAN; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

EID: 0031439025     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(97)90136-0     Document Type: Article

References (68)

1. Anand BK: Nervous regulation of food intake. Am J Clin Nutr 8:529-534, 1960
2. Morley JE: Neuropeptide regulation of appetite and weight. Clin Endocrinol (Oxf) 28:675-689, 1987
3. Berelowitz M, Bruno JF, White JD: Regulation of hypothalamic neuropeptide expression by peripheral metabolism. Trends Endocrinol Metab 3:127-133, 1992
4. Leibowitz SF: Central physiological determinants of eating behavior and weight, in Brownell D, Fairburn CG (eds): Eating Disorders and Obesity. New York, NY, Guilford, 1995, pp 3-7
5. Kopelman PG: Neuroendocrine function in obesity. Clin Endocrinol (Oxf) 28:675-689, 1988
6. Sahu A, Kalra SP: Neuropeptidergic regulation of feeding behavior - Neuropeptide Y. Trends Endocrinol Metab 4:217-224, 1993
7. Gibbs J, Smith GP: Effects of brain-gut peptides on satiety, in Bjorntorp P, Brocloff BN (eds): Obesity. Philadelphia, PA, Lippincott, 1992, pp 399-410
8. Leibowitz SF, Shor-Posner G: Brain serotonin and eating behavior. Appetite 7:1-14, 1986 (suppl)
9. Tatemoto K, Carlquist M, Mutt V: Neuropeptide Y: A novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659-660, 1984
10. Clark JT, Kalra PS, Crowley WR, et al: Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology 115:427-429, 1984
11. Kalra SP, Kalra PS: Neuropeptide Y: A novel peptidergic signal for the control of feeding behavior. Curr Top Neuroendocrinol 10:192-217, 1990
12. Clark JT, Kalra PS, Kalra SP: Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. Endocrinology 117:2435-2442, 1985
13. Leibowitz SF: Hypothalamic neuropeptide Y in relation to energy balance. Ann NY Acad Sci 611:284-301, 1990
14. Borisova EV, Kadar T, Telegdy G: Bimodal effect of neuropeptide Y on feeding and its antagonism by receptor blocking agents in rats. Acta Physiol Hung 78:301-308, 1991
15. Gray TS, Morley JE: Neuropeptide Y: Anatomical distribution and possible function in mammalian nervous system. Life Sci 38:389-401, 1986
16. Ekblad E, Winther C, Ekman R, et al: Projection of neuropeptide containing peptides in rat small intestine. Neuroscience 20:169-188, 1987
17. Bennet WM, Wang ZL, Jong P, et al: Presence of neuropeptide Y and its messenger ribonucleic acid in human islets: Evidence for a possible paracrine role. J Clin Endocrinol Metab 81:2117-2120, 1996
18. O'Donohue TL, Chronwall BM, Pruss M, et al: Neuropeptide Y and peptide YY neuronal and endocrine systems. Peptides 6:755-768, 1985
19. Zhang Y, Proenca R, Maffei M, et al: Positional cloning of the mouse obese gene and its human homologue. Nature 372:425-431, 1994
20. Schwartz MW, Baskin DG, Bukowski TR, et al: Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice. Diabetes 45:531-535, 1996
21. Hauner H: Adipocytes as a source and target of hormones: Recent developments in adipose tissue physiology. Eating Patterns Weight Control 5:2-5, 1996
22. Tatemoto K, Rökaeus A, Jornvall H, et al: Galanin - A novel biologically active peptide from porcine intestine. FEBS Lett 164:124-128, 1983
23. Rökaeus A: Galanin, a newly isolated biologically active neuropeptide. Trends Neurosci 10:158-164, 1987
24. Bauer FE, Christofides ND, Hacker GW, et al: Distribution of galanin immuno-reactivity in the genitourinary tract of man and rat. Peptides 7:5-10, 1986
25. Kaplan LM, Gabriel SM, Koenig JI, et al: Galanin is an estrogen-inducible, secretory product of the rat anterior pituitary. Proc Natl Acad Sci USA 85:7408-7412, 1988
26. Koenig JI, Gabriel SM, Kaplan LM: Galanin: A potentially significant neuroendocrine modulator, in Barnes CD, Johnston CA (eds): Brain-Gut Peptides and Reproductive Function. Boca Raton, FL, CRC, 1991, pp 194-208
27. Hyde JF, Engle MG, Maley BE: Colocalization of galanin and prolactin within secretory granules of anterior pituitary cells in estrogentreated Fisher 344 rats. Endocrinology 129:270-276, 1991
28. Gabriel SM, Koening JI, Kaplan LM: Galanin-like immunoreactivity is influenced by estrogen in prepubertal and adult rats. Neuroendocrinology 51:168-173, 1990
29. Hemmer A, Hyde JF: Regulation of galanin secretion from pituitary cells in vitro by estradiol and GH-RH. Peptides 13:1201-1206, 1992
30. Hyde JF, Bartke A, Davis BM: Galanin gene expression in the hypothalamo-pituitary axis of the Ames dwarf mouse. Mol Cell Neurosci 4:298-303, 1993
31. Baranowska B, Singh SP, Soszynski P, et al: The role of opiate, dopaminergic and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity. Acta Endocrinol (Copenh) 116:221-228, 1987
32. Baranowska B, Rozbicka G, Jeske W, et al: The role of endogenous opiates in the mechanism of inhibited luteinizing hormone (LH) secretion in women with anorexia nervosa: The effect of naloxone on LH, follicle-stimulating hormone, prolactin, and β-endorphin secretion. J Clin Endocrinol Metab 59:412-416,1984
33. Baranowska B: A marked decrease of vasoactive intestinal peptide release in obese patients. Metabolism 40:344-346, 1991
34. Baranowska B: Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa? Psychoendocrinology 15:371-379,1990
35. Feighner SP, Robins E, Guza SB, et al: Diagnostic criteria for use in psychiatric research. Arch Gen Psychol 26:57-63, 1972
36. Russell CFM: Anorexia nervosa, its identity as an illness and its treatment, in Price IH (ed): Modern Trends in Psychological Medicine. London, UK, Butterworth, 1979, pp 131-135
37. Mulvihill SJ, Debas HT: Regulatory peptides of the gut, in Greenspan FS, Baxter JD (eds): Basic and Clinical Endocrinology. Norwalk, CT, Appleton & Lange, 1994, pp 551-554
38. Strombom U, Krotkiewski M, Blennow K, et al: The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution. Int J Obes Relat Metab Disord 20:361-368, 1996
39. Sahu A, Kalra SP: Neuropeptidergic regulation of feeding behavior - Neuropeptide Y. Trends Endocrinol Metab 4:217-224, 1993
40. Williams G, Steel JH, Cardoso H, et al: Increased hypothalamic neuropeptide Y concentrations in diabetic rats. Diabetes 37:763-772, 1988
41. Sahu A, Sninsky CA, Kalra SP: Neuropeptide Y concentration in microdissected hypothalamic regions and in vitro release from the medial basal hypothalamus-preoptic area of streptozotocin-diabetic rats with and without insulin substitution therapy. Endocrinology 126:192-198, 1990
42. Beck B, Burlet A, Nicolas JP, et al: Hypothalamic neuropeptide Y (NPY) in obese Zucker rats: Implications in feeding and sexual behavior. Physiol Behav 47:419-453, 1990
43. Stricker-Krongrad A, Beck B, Nicolas JP, et al: Microstructure of feeding behavior induced by neuropeptide Y in the Zucker rat. Int J Obes Relat Metab Disord 17:73, 1992 (suppl 2, abstr)
44. Stricker-Krongrad A, Beck B, Burlet A, et al: Dietary preference for carbohydrate or fat is related to neuropeptide Y variations in a specific hypothalamic network. Int J Obes Relat Metab Disord 17:102, 1993 (suppl 2, abstr)
45. Leibowitz SF, Xuereb M, Kim T: Blockade of natural and neuropeptide Y-induced carbohydrate feeding by a receptor antagonist PYX-2. Neuroreport 3:1023-1026, 1992
46. Zarjevski N, Cusin I, Vettor R, et al: Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology 133:1753-1758, 1993
47. Zarjevski N, Cusin I, Vettor R, et al: Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 43:764-769, 1994
48. Moltz JH, McDonald JK: Neuropeptide Y: Direct and indirect action on insulin secretion in the rat. Peptides 6:1155-1159, 1985
49. Schwartz MW, Figlewicz DP, Baskin DG, et al: Insulin in the brain, a hormonal regulator of energy balance. Endocr Rev 13:387-414, 1992
50. Lauterio TJ, Aravich FF, Rotwein P: Divergent effects of insulin-like growth factor II gene expression in the rat hypothalamus. Endocrinology 126:392-398, 1990
51. Baranowska B, Wasilewska-Dziubińska E, Radzikowska M, et al: Neuroendocrine disturbances in obesity. Int J Obes Relat Metab Disord 18:28, 1994 (suppl 2, abstr)
52. Bray GA: Food intake, sympathetic activity and adrenal steroids. Brain Res Bull 32:537-541, 1993
53. Giacobino JP: β3-Adrenoceptor - An update. Eur J Endocrinol 132:377-385, 1995
54. Muzzini P, Revelli JP, Kuhne F, et al: An adipose tissue-specific β-adrenergic receptor. Molecular cloning and down-regulation in obesity. J Biol Chem 266:24053-24058, 1991
55. Breslow MI, Sadovnikoff N, Di Silvestre D, et al: Reduced beta 3-adrenoceptor (β3-AR) mRNA expression in obese diabetic db/db mice. Tenth International Congress of Endocrinology, June 12-15, 1996, San Francisco, CA (abstr Pl 858, 349)
56. Dallman MF, Ahana SF, Strach AM, et al: The neural network that regulates energy balance is responsive to glucocorticoids and insulin and also regulates HPA axis responsivity at a site proximal to CRF neurons. Ann NY Acad Sci 771:730-742, 1995
57. Frankish HM, Dryden S, Hopkins D, et al: Neuropeptide Y, the hypothalamus, and diabetes: Insights into the central control of metabolism. Peptides 16:757-771, 1995
58. van Huijsuijnen OB-H, Rohner-Jeanrenaud F, Jeanrenaud B: Hypothalamic Neuropeptide Y messenger ribonucleic acid levels in pre-obese and genetically obese (fa/fa) rats: Potential regulation thereof by corticotropin-releasing factor. J Neuroendocrinol 5:381-386, 1993
59. Lonnquist F, Thorne A, Nilsell K, et al: A pathogenic role of visceral fat β3-adrenoreceptors in obesity. J Clin Invest 95:1109-1116, 1995
60. Lee GH, Proenca R, Montez JM, et al: Abnormal splicing of the leptin receptor in diabetic mice. Nature 379:632-635, 1996
61. Grinspoon S, Gulick T, Askari H, et al: Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab 81:3861-3863, 1996
62. Considine RV, Sinha MK, Helman ML, et al: Serum immunoreactive-leptin concentrations in normal-weight and obese humans. N Engl J Med 344:292-295, 1996
63. Chua SC, Chung WK, Wu-Peng XS, et al: Phenotypes of mouse diabetes and rat fatty due to mutations in the ob (leptin) receptor. Science 271:994-996, 1996
64. Leibowitz SF: Possible contribution of brain peptides to the development of eating disorders and obesity. Int J Obes Relat Metab Disord 18:85, 1994 (suppl 2, abstr)
65. Invitti C, Brunani A, Pasqualinotto L, et al: Plasma galanin concentrations in obese, normal weight and anorectic women. Int J Obes 19:347-349, 1995
66. Ekblad E, Edvinsson L, Wahlestedt C, et al: Neuropeptide Y co-exists and cooperates with noradrenaline in perivascular nerve fibers. Regul Pept 8:225-235, 1984
67. Lundberg JM, Hua X, Franco-Cerecede A: Effects of NPY on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig. Acta Physiol Scand 121:325-332, 1984
68. Lundberg JM, Saria A, Anggard A, et al: Neuropeptide Y and noradrenaline interactions in peripheral cardiovascular control. Clin Exp Hypertens A6:1961-1972, 1984